At BILBOMÁTICA, an ALTIA Company, we pride ourselves on being at the forefront of technological innovation , especially in areas that have a direct impact on improving people's quality of life . That's why we are particularly pleased with LUCIA , a project in which BILBOMÁTICA is developing the eCRF (Electronic Case Report Form) system , a revolutionary tool for collecting and managing clinical data focused on the fight against lung cancer .
Our contribution to the LUCIA project through the development of the eCRF is a clear testament to our commitment to excellence and innovation. This system is not just a platform; it is the result of countless hours of work , meticulously designed to be customizable, standardized, and , above all , focused on providing the best user experience for healthcare professionals . We have strived to create a tool that not only meets expectations but exceeds them, perfectly adapting to the specific needs of medical research in the field of lung cancer .
Alignment with directives and collaborations
Our work on the eCRF and the LUCIA project aligns perfectly with European directives on early cancer detection, marking a significant milestone in our commitment to public health and lung cancer prevention. Furthermore, collaboration with renowned organizations such as Osakidetza ,Biobizkaia , and FISEVI broadens our reach and reinforces the importance of our work, positioning us as leaders in the field.
The implementation of eCRF in the clinical research process represents a significant advancement in how data is collected and managed . Reducing human error and improving data accuracy are fundamental to the success of clinical studies. Furthermore, the ability to facilitate international collaboration through real-time remote access is a game-changer, allowing us to work more efficiently and effectively than ever before.
At BILBOMÁTICA, we firmly believe in the power of technology to change lives. Our work on the LUCIA project and the development of the eCRF system is a clear example of how technological innovation can have a real impact on public health. We are proud to contribute to the fight against lung cancer and committed to continuing our work to improve early detection and clinical research.
The LUCIA project receives funding from the European Union's Horizon Europe research and innovation programme under grant agreement 101096473 .